Avidity Biosciences Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 14, 2023 / 09:20PM GMT
Joe Schwartz - SVB Securities LLC - Analyst

Hello, and welcome to this fireside chat with Avidity Biosciences. I'm Joe Schwartz at SVB Securities. It's my pleasure to be joined by Sarah Boyce, President and Chief Executive Officer; and Steve Hughes, Chief Medical Officer. Thanks so much for joining us today. Maybe --

Sarah Boyce - Avidity Biosciences, Inc. - President & CEO

You're welcome, Joe. It's a pleasure, and thank you as always for inviting us and including us in your conference.

Joe Schwartz - SVB Securities LLC - Analyst

So it's certainly exciting time at the company. So I'd love to have you start us off with a brief overview of your key initiatives that are ongoing now and how they'll be generating news flow over the next year or so.

Sarah Boyce - Avidity Biosciences, Inc. - President & CEO

Yeah, yeah. Absolutely. Thanks, Joe. And it is like an incredibly exciting time for us. We now have three programs in the clinic. AOC 1001 that I think we all know well,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot